Noninvasive predictors of clinically significant portal hypertension in <scp>NASH</scp> cirrhosis: Validation of <scp>ANTICIPATE</scp> models and development of a lab‐based model-Reference-Cited by-同舟云学术

Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab‐based model

Published:2022-10-10 Issue:12 Volume:6 Page:3324-3334
ISSN:2471-254X
Container-title:Hepatology Communications
language:en
Short-container-title:Hepatology Communications

Author:

Rabiee Anahita¹^ORCID,Deng Yanhong²,Ciarleglio Maria²,Chan Jean L.³,Pons Monica⁴,Genesca Joan⁴⁵^ORCID,Garcia‐Tsao Guadalupe¹⁶

Affiliation:

1. Section of Digestive Diseases Yale School of Medicine New Haven Connecticut USA

2. Department of Biostatistics School of Public Health, Yale University New Haven Connecticut USA

3. Conatus Pharmaceuticals at the time of study conduct San Diego California USA

4. Liver Unit, Department of Internal Medicine Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona Barcelona Spain

5. Centro de Investigacion Biomédica en Red de Enfermedades Hepáticas y Digestivas Instituto de Salud Carlos III Madrid Spain

6. VA‐CT Healthcare System New Haven Connecticut USA

Funder

Yale Liver Center

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep4.2091

Reference30 articles.

1. Hepatic Venous Pressure Gradient Predicts Clinical Decompensation in Patients With Compensated Cirrhosis